Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110475 · Cited by 1,027

Viral myocarditis—diagnosis, treatment options, and current controversies

Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657

Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices — United States, June 2021

Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7027e2 · Cited by 587

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 437

Computing Adjusted Risk Ratios and Risk Differences in Stata

Norton, E. C., Miller, M. M., & Kleinman, L. C. (2013) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300304 · Cited by 299

What's the Risk? A Simple Approach for Estimating Adjusted Risk Measures from Nonlinear Models Including Logistic Regression

Kleinman, L. C., & Norton, E. C. (2008) · Health Services Research · doi:10.1111/j.1475-6773.2008.00900.x · Cited by 287

Myocarditis associated with Covid‐19 disease: A systematic review of published case reports and case series

Rathore, S. S., Rojas, G. A., Sondhi, M., Pothuru, S., Pydi, R., Kancherla, N., Singh, R., Ahmed, N. K., Shah, J., Tousif, S., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14470 · Cited by 83

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Murk, W. K., Gierada, M., Fralick, M., Weckstein, A. R., Klesh, R., & Rassen, J. A. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.201686 · Cited by 64

Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-Like Syndrome in Adults

Most, Z. M., HENDREN, N. S., Drazner, M. H., & Perl, T. M. (2020) · Circulation · doi:10.1161/circulationaha.120.050166 · Cited by 49

Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2

Vukomanovic, V. A., Krasić, S., Prijić, S., Ninić, S., Minic, P. B., Petrović, G., & Nešić, D. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003094 · Cited by 28

HLA binding‐groove motifs are associated with myocarditis induction after Pfizer‐BioNTech BNT162b2 vaccination

Aharon, A., Benedek, G., Barhoum, B., Parnasa, E., Magadle, N., Perzon, O., & Mevorach, D. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14142 · Cited by 11

Comparison of febrile seizures in children with or without coronavirus disease‐2019: A single‐center observational study

Seo, M. J., Yum, M. S., & Park, J. S. (2022) · Pediatrics International · doi:10.1111/ped.15461 · Cited by 11

Long COVID and its cardiovascular consequences: What is known?

Składanek, J. A., Leśkiewicz, M., Gumiężna, K., Baruś, P., Piasecki, A., Klimczak‐Tomaniak, D., Sygitowicz, G., Kochman, J., Grabowski, M., & Tomaniak, M. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/167482 · Cited by 11

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2024 vaccines in the United Kingdom

Kohli, M. A., Maschio, M., Lee, A., Joshi, K., Carroll, S., Balogh, O., de Velde, N. V., & Beck, E. C. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2413288 · Cited by 10

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease

Naiditch, H., Betts, M. R., Larman, H. B., Levi, M., & Rosenberg, A. Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1376654 · Cited by 10

Global, regional and national epidemiology of myocarditis: health inequalities, risk factors and forecasted burden based on the Global Burden of Disease Study 2021

Li, C., Xu, K., Du, A., Fu, N., Xu, Z., & Chang, Q. (2025) · Heart · doi:10.1136/heartjnl-2024-325523 · Cited by 10

COVID‐19 implications for pediatric anesthesia: Lessons learnt and how to prepare for the next pandemic

Afshari, A., Disma, N. M., von Ungern-Sternberg, B. S., & Matava, C. T. (2021) · Pediatric Anesthesia · doi:10.1111/pan.14347 · Cited by 10

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review

FERGIE, J. E., Moran, M. M., Cane, A. D., Pather, S., Türeci, Ö., & Srivastava, A. K. (2022) · Vaccines · doi:10.3390/vaccines10122039 · Cited by 10

Magnetic Resonance Imaging of Cardiovascular Manifestations Following COVID ‐19

Tijmes, F. S., Marschner, C., Thavendiranathan, P., & Hanneman, K. A. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28677 · Cited by 10

Myocarditis in COVID-19: a focus on the pediatric population.

Sleem, B., Zareef, R. O., Bitar, F. F., & Arabi, M. T. (2023) · PubMed Central · Cited by 10

Treatment of multisystem inflammatory syndrome in children

Tong, T., Jin, Y.-H., Wang, M., & Gong, F. (2024) · World Journal of Pediatrics · doi:10.1007/s12519-024-00798-y · Cited by 12

Hospital Outcomes Among COVID-19 Hospitalizations With Myocarditis from the California State Inpatient Database

Rubens, M., Ramamoorthy, V., Saxena, A., Zevallos, J. C., Ruíz, J. G., Ahmed, M. A., Zhang, Z., McGranaghan, P., Veledar, E., Jimenez, J., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.08.009 · Cited by 10

Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk

Alejo, J. L., Kim, J. D., Chiang, T. P., Avery, R. K., Karaba, A. H., Jefferis, A. A., Warren, D. S., Massie, A. B., Tobian, A. A. R., Segev, D. L., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.14913 · Cited by 10

Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers

Grant, W. B. (2024) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2023.12.007 · Cited by 10

Sex differences in mitochondrial gene expression during viral myocarditis

Florio, D. N. D., Weigel, G. J., Gorelov, D. J., McCabe, E. J., Beetler, D. J., Shapiro, K. A., Bruno, K. A., Chekuri, I., Jain, A., Whelan, E. R., et al. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00678-0 · Cited by 10

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?

Esposito, S., Caminiti, C., Giordano, R., Argentiero, A., Ramundo, G., & Principi, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915580 · Cited by 8

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective

Alami, A., Villeneuve, P. J., Farrell, P. J., Mattison, D. R., Farhat, N., Haddad, N., Wilson, K. R., Gravel, C. A., Crispo, J. A. G., Perez‐Lloret, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154971 · Cited by 10

Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US

McGrath, L. J., Moran, M. M., Alfred, T., Reimbaeva, M., Fusco, M. D., Khan, F. L., Welch, V., Malhotra, D., Cane, A. D., & Lopez, S. M. C. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1261046 · Cited by 9

Immune Response in Myocardial Injury: In Situ Hybridization and Immunohistochemistry Techniques for SARS-CoV-2 Detection in COVID-19 Autopsies

Chong, P. Y., Iqbal, J., Yeong, J. P.-S., Aw, T. C., Chan, K. S., & Chui, P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.658932 · Cited by 9

Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies

Keshavarz, P., Yazdanpanah, F., Emad, M., Hajati, A., Nejati, S. F., Sadabad, F. E., Azrumelashvili, T., Mizandari, M., & Raman, S. S. (2022) · Tomography · doi:10.3390/tomography8040164 · Cited by 9

Nationwide Analysis of the Clinical Outcomes of Patients Admitted With COVID-19 Infection With Myocarditis and Racial Disparities in Mortality

Cannon, H. R., Bobba, A., Shekhar, R., Gangu, K., Sagheer, S., Chourasia, P. K., Garg, I., Shuja, H., Wasty, N., & Sheikh, A. B. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101481 · Cited by 9

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada

Buchan, S. A., Alley, S., Seo, C. Y., Johnson, C., Kwong, J. C., Nasreen, S., Thampi, N., Lu, D., Harris, T. M., Calzavara, A. J., et al. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.6166 · Cited by 9

Global, regional, and national burden of myocarditis and its attributable risk factors in 204 countries and territories from 1990 to 2021: updated systematic analysis

Ren, J., Liu, W., Jin, X., Zhang, C., Xu, X., Deng, G., Gao, X.-M., Li, J., Li, R., Zhang, X., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1542921 · Cited by 10

National Trends in Heart Failure and Acute Myocarditis–Related Death Before and During the COVID‐19 Pandemic

Siddiqi, R. L., Farhan, S. H., Shah, S., Mushahid, H., Nasir, M. M., & Moukarbel, G. V. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038987 · Cited by 8

Importance of Coronavirus Disease 2019 Vaccination in Children: Viewpoint and Recommendations of the Union of European National Societies of Pediatrics

Pettoello‐Mantovani, M., Cardemil, C. V., Cohen, R., Lévy, C., Giardino, I., Indrio, F., & Somekh, E. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.12.066 · Cited by 9

Myocarditis Related to COVID-19 and SARS-CoV-2 Vaccination

Molina-Ramos, A. I., Moyano, E. G., Rodríguez‐Capitán, J., Angullo-Gómez, M., Gallardo-Jiménez, P., de Pedro, I. P., de Santis, L. V., Pérez-Villardón, B., Piñero-Uribe, I., Mora-Robles, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236999 · Cited by 8

In-Hospital Outcomes of COVID-19 Associated Myocarditis (from a Nationwide Inpatient Sample Database Study)

Sattar, Y., Sandhyavenu, H., Patel, N. N., Victor, V., Patel, D., Hussain, B., Titus, A., Thyagaturu, H. S., Alraiyes, M., Atti, L., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.01.004 · Cited by 8

Presentations, Diagnosis, and Treatment of Post-COVID Viral Myocarditis in the Inpatient Setting: A Narrative Review

Sayegh, M. N., Goins, A. E., Hall, M. A. K., & Shin, Y. M. (2023) · Cureus · doi:10.7759/cureus.39338 · Cited by 8

The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan

Fust, K., Joshi, K., Beck, E. C., Maschio, M., Kohli, M. A., Lee, A., Hagiwara, Y., de Velde, N. V., & Igarashi, A. (2024) · Vaccines · doi:10.3390/vaccines12040434 · Cited by 8

Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period

Aquaro, G. D., Licordari, R., Todiere, G., Ianni, U., Dellegrottaglie, S., Restivo, L., Grigoratos, C., Patanè, F., Barison, A., Micari, A., et al. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001330 · Cited by 9

Global epidemiology of myocarditis: disparities in age, sex and geography

Klingel, K., Tschöpe, C., Yon, D. K., Mensah, G. A., Weber, B. N., Kontorovich, A., Lee, S., Cooper, L. T., & Ammirati, E. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01276-w · Cited by 9

COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Xenobiotics)

Chary, M. A., Barbuto, A. F., Izadmehr, S., Tarsillo, M., Fleischer, E., & Burns, M. M. (2022) · Journal of Medical Toxicology · doi:10.1007/s13181-022-00918-y · Cited by 7

Myocarditis – A silent killer in athletes: Comparative analysis on the evidence before and after COVID-19 pandemic

Name, J. V., Wu, K., & Xi, L. (2024) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2024.03.003 · Cited by 8

Myocarditis incidence and hospital mortality from 2007 to 2022: insights from a nationwide registry

Rottmann, F. A., Glück, C., Kaier, K., Bemtgen, X., Supady, A., Mühlen, C. V. Z., Westermann, D., Wengenmayer, T., & Staudacher, D. L. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02494-3 · Cited by 9

Myocarditis and Pericarditis are Temporally Associated with BNT162b2 COVID-19 Vaccine in Adolescents: A Systematic Review and Meta-analysis

Choi, Y., Lee, J. S., Choe, Y. J., Lee, H., Yoon, Y., Shin, S. H., Hwang, M.-J., Choi, H., Na, S., Kim, J. H., et al. (2024) · Pediatric Cardiology · doi:10.1007/s00246-024-03618-2 · Cited by 7

Dynamic Masking: A Proposal of Burden‐Based Metrics for Masking in K‐12 Schools During the COVID ‐19 Pandemic

Rowland, L. C., Klinkhammer, M. D., & Ramirez, D. W. E. (2021) · Journal of School Health · doi:10.1111/josh.13099 · Cited by 7

Pediatrician’s role in vaccinating children and families for COVID-19: no one left behind

Maurice, A. D. S., Cheng, T. L., Devaskar, S. U., Shah, S. I., Raphael, J. L., Patel, M. S., Davis, J. W., Pursley, D. M., Cheng, T. L., Devaskar, S. U., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01804-z · Cited by 6

The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis

Klamer, T. A., Linschoten, M., & Asselbergs, F. W. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01677-9 · Cited by 10

Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next

Corey, K. B., Koo, G., & Phillips, E. J. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.035 · Cited by 9

Paving the Way Towards Precision Vaccinology: The Paradigm of Myocarditis After Coronavirus Disease 2019 (COVID-19) Vaccination

Lagousi, T., Papadatou, I., Strempas, P., Chatzikalil, E., & Spoulou, V. I. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac396 · Cited by 7

COVID-19: A Pediatric Update in Epidemiology, Management, Prevention, and Long-term Effects

Inagaki, K., & Hobbs, C. V. (2023) · Pediatrics in Review · doi:10.1542/pir.2022-005686 · Cited by 7

A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination

Kim, S. H., Lee, S. Y., Kim, G. Y., Oh, J. S., Kim, J., Chun, K. J., Ju, M. H., Lee, C.-H., Song, Y., & Na, J. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e104 · Cited by 7

Acute myocardial infarction in patients with multiple sclerosis; An insight from 1785 cases in the United States

Ramphul, K., Kumar, N., Verma, R., Ramphul, Y., Sombans, S., Kumari, K., Fnu, A., & Lohana, P. J. D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104140 · Cited by 6

Myocarditis in SARS-CoV-2: A Meta-Analysis

Thaker, R., Faraci, J., Derti, S., & Schiavone, J. F. (2023) · Cureus · doi:10.7759/cureus.48059 · Cited by 9

The Potential Mechanisms of Arrhythmia in Coronavirus disease-2019

Li, J., Huang, Q., Liang, Y., Jiang, J., Yang, Y., Feng, J., Tan, X., & Li, T. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94578 · Cited by 6

Sinigrin Selectively Mitigates the Acute‐Cardiac Inflammatory Response Through an AMPK ‐Dependent Mechanism

Veeram, A., Patekar, R. R., Bharate, S. B., Andugulapati, S. B., & Sistla, R. (2025) · Phytotherapy Research · doi:10.1002/ptr.8453 · Cited by 6

Review of Immunologic Manifestations of COVID-19 Infection and Vaccination

Pozdnyakova, V., Weber, B., Cheng, S. C., & Ebinger, J. E. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.03.006 · Cited by 6

The Cardiovascular Manifestations of COVID-19

Louis, D. W., Saad, M. S., Vijayakumar, S., Ilyas, S., Kokkirala, A. R., & Aronow, H. D. (2023) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.08.001 · Cited by 9

YouTube and COVID-19 vaccines: A mini scoping review

Narayanan, S., & Basch, C. H. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2202091 · Cited by 6

Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective

Bandyopadhyay, S., Rajan, M. V., Kaur, P., & Hariprasad, G. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101493 · Cited by 6

Cardiovascular effects of COVID-19 in children

Broberg, M. C. G., Mazer, M. B., & Cheifetz, I. M. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.202386 · Cited by 7

Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study

Liu, G., Chen, T., Zhang, X., Hu, B., & Shi, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1271959 · Cited by 6

COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future

Park, J., & Kim, K. H. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0065 · Cited by 6

Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster

Singh, A., Lam, N. D., Everest, S., Afzal, S., & Shim, A. (2022) · Cureus · doi:10.7759/cureus.22148 · Cited by 6

Cardiopulmonary crosstalk in Long COVID: a systematic review of emerging evidence

Arab, Z., Shayanfar, N., Mojaver, M. R., Khormali, M., Boskabady, M. H., & Niazmand, S. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05185-7 · Cited by 7

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection

Naveed, Z., Chu, C., Tadrous, M., Veroniki, A.-A., Li, J., Rouleau, I., Febriani, Y., Calzavara, A. J., Buchan, S. A., Nasreen, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26551 · Cited by 5

Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example

Bots, S. H., Belitser, S. V., Groenwold, R. H. H., Durán, C. E., Riera‐Arnau, J., Schultze, A., Messina, D., Segundo, E., Douglas, I., Carreras, J. J., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae172 · Cited by 6

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era

Gradone, A., Ma, V. T.-L., Vasbinder, A. L., Fecher, L. A., Yentz, S. E., Hayek, S. S., & Lao, C. D. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03803-5 · Cited by 5

Comparison of mortality and cardiovascular complications due to COVID-19, RSV, and influenza in hospitalized children and young adults

Khanal, S., Khanal, B., Chou, F., Moon‐Grady, A. J., & Ghimire, L. V. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04366-0 · Cited by 5

Impact of the COVID-19 pandemic on cardiac magnetic resonance imaging practices: insights from the MRCT registry

Moser, L. J., Lisi, C., Gutberlet, M., Boccalini, S., Budde, R. P. J., Francone, M., Paar, M. H., Loewe, C., Muscogiuri, G., Natale, L., et al. (2025) · European Radiology · doi:10.1007/s00330-025-11464-w · Cited by 5

Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine

Pasha, M. A., Isaac, S. P., & Khan, Z. H. (2022) · Cureus · doi:10.7759/cureus.26650 · Cited by 5

Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines

Kassianos, G. C., MacDonald, P., Aloysius, I., & Pather, S. (2024) · Vaccines · doi:10.3390/vaccines12010057 · Cited by 5

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand

Walton, M., Pletzer, V., Teunissen, T., Lumley, T., & Hanlon, T. (2023) · Drug Safety · doi:10.1007/s40264-023-01332-1 · Cited by 4

Myocardial injury: a future challenge for long-COVID-19 complications

Szarpak, Ł., Jaguszewski, M. J., Pruc, M., & Rafique, Z. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab067 · Cited by 5

How Can We Best Use COVID-19 Vaccines in Adolescents? A Perspective From the United States

Tyungu, D. L., O’Leary, S. T., & Middleman, A. B. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.09.008 · Cited by 5

Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents

Tsang, T. K., Sullivan, S. G., Meng, Y., Lai, F. T. T., Fan, M., Huang, X., Lin, Y., Peng, L., Zhang, C., Yang, B., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03597-4 · Cited by 5

A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic

Mues, K. E., Zhou, C. K., Gerber, J. E., van Hunsel, F. P. A. M., Klein, N. P., Izurieta, H. S., & Chen, R. T. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127691 · Cited by 4

Edukasi Gizi Seimbang Bagi Remaja Melalui Media Audio Visual

Hartaty, H., Arda, D., & Menga, M. K. (2022) · Abdimas Polsaka · doi:10.35816/abdimaspolsaka.v1i2.18 · Cited by 4

Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions

Ulucay, A. S., Singh, G., & Kanuri, S. H. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.06.009 · Cited by 4

Toxicologic Pathology Forum: mRNA Vaccine Safety–Separating Fact From Fiction

Sellers, R. S., & Dormitzer, P. R. (2024) · Toxicologic Pathology · doi:10.1177/01926233241278298 · Cited by 4

Imaging Findings in Pediatric COVID-19: A Review of Current Literature

Fick, T. A., Cua, C. L., & Lee, S. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00256-8 · Cited by 4

Systematic review of case reports on COVID-19 associated myocarditis: a discussion on treatments

Lim, V., Topiwala, G., Apinova, E., & Diioia, M. (2024) · Virology Journal · doi:10.1186/s12985-024-02499-4 · Cited by 4

COVID-19 mRNA vaccination in patients with previous myocarditis

Pieroni, M., Ciabatti, M., Saletti, E., D’Aniello, E., Bolognese, L., & on-behalf-of-the-COVID-Vaccine-in-myocarditis-study-group (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.07.011 · Cited by 4

Difficulties in diagnosis of SARS-CoV-2 myocarditis in an adolescent

Callegari, A., Klingel, K., Kelly, J., Berger, C., Geiger, J., & Knirsch, W. (2022) · Swiss Medical Weekly · doi:10.4414/smw.2022.w30214 · Cited by 4

Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemicPreprint

Nyberg, F., Lindh, M., Vanfleteren, L. E. G. W., Hammar, N., Wettermark, B., Sundström, J., Santosa, A., Kirui, B. K., & Gisslén, M. (2021) · medRxiv · doi:10.1101/2021.10.04.21263507 · Cited by 4

Myocarditis after RNA-based COVID-19 vaccines: Where do we stand?

Moroni, F., Mbualungu, J., & Abbate, A. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.03.014 · Cited by 3

Vaccinating adolescents in England: a risk-benefit analysisPreprint

Gurdasani, D. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/grzma · Cited by 4

The Neuro-Immune Axis in Cardiomyopathy: Molecular Mechanisms, Clinical Phenotypes, and Therapeutic Frontiers

Saha, D., Dutta, P., & Chakraborty, A. (2025) · Immuno · doi:10.3390/immuno5040045 · Cited by 3

A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023

Oh, D., Hölzer, M., Börnigen, D., Paraskevopoulou, S., Duwe, S. C., Budt, M., Kerber, R., Mikołajewska, A., Böttcher, S., Seifried, J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01093-1 · Cited by 4

Sex differences in coronavirus disease 2019 myocarditis

Beetler, D. J., & Fairweather, D. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100704 · Cited by 3

Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review

Satyam, S. M., El‐Tanani, M., Bairy, L. K., Rehman, A., Srivastava, A., Kenneth, J. M., & Prem, S. M. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09954-2 · Cited by 3

COVID-19 and Myocarditis: Pathogenetic Mechanisms and Histological Features

Salzillo, C., & Marzullo, A. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70010003 · Cited by 4

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

Zeevat, F., van der Pol, S., Westra, T. A., Beck, E. C., Postma, M. J., & Boersma, C. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03112-y · Cited by 4

Identification of Potential Biomarkers and Immune Cell Signatures in COVID‐19 Myocarditis Through Bioinformatic Analysis

Song, Y., Wang, X., Tong, D., Huang, X., Jin, X., Zhang, C., Liu, J., Guo, B., Huang, C., & Lian, J. (2025) · Cardiology Research and Practice · doi:10.1155/crp/2349610 · Cited by 3

Comparison of COVID−19-associated inpatient burden by variant period in hospitalized children age <5 years in the United States

Andersen, K. M., McColgan, M. D., Cane, A. D., Moran, M. M., Reimbaeva, M., & Lopez, S. M. C. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1573933 · Cited by 3

Public Interest in Myocarditis during the SARS-CoV-2 Pandemic

Perkins, D., Wilkins, R., Kerr, R., Greiner, B. H., & Hartwell, M. L. (2023) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2022.307 · Cited by 3

Sudden cardiac death in myocarditis

Тарадин, Г. Г., Игнатенко, Г. А., & Евгеньевна, К. Т. (2023) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2023-51-010 · Cited by 3

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors

Zwiers, L. C., Ong, D. S. Y., & Grobbee, D. E. (2023) · Global Heart · doi:10.5334/gh.1252 · Cited by 3

Contemporary National Trends of Mechanical Circulatory Support Among Myocarditis Hospitalizations Before the Pandemic: A National In-patient Database (2005-2019) Study

Shah, R. P., Duhan, S., Alharbi, A. A., Sattar, Y., Gonuguntla, K., Alhajji, M., & Jagadeesan, V. S. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102020 · Cited by 4

Myocarditis in children 2024, new themes and continued questions

Goldberg, J. F., Spinner, J. A., & Soslow, J. H. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001151 · Cited by 4

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France

Lee, A., Davido, B., Beck, E. C., Demont, C., Joshi, K., Kohli, M. A., Maschio, M., Uhart, M., & Mouaddin, N. E. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2423474 · Cited by 3

Year 3 of COVID-19: Harsh Truths, Brutal Realities, and Glimmers of Hope

Poland, G. A., Issa, M., & Sundsted, K. K. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.10.022 · Cited by 3

Post-COVID mRNA vaccine myocarditis in children: report of two cases

Shamekh, A., Powell, C., Ashabani, A., & Abdelgadir, I. S. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-253383 · Cited by 3

A Case of COVID-19-Induced Delayed-Onset Myocarditis

Vũ, V. H., Nguyen, M. T., Nguyen, K. D., Pham, T. T. H., & Truong, B. Q. (2022) · American Journal of Case Reports · doi:10.12659/ajcr.935577 · Cited by 3

From discovery through emergency use to the present: Safety evaluation of the COVID-19 mRNA-1273 (Moderna) vaccine

Straus, W. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2653369 · Cited by 3

The Impact of COVID-19 on the Cardiovascular Health of Emerging Adults Aged 18-25: Findings From a Scoping Review

Rezler, Z., Ko, E., Jin, E., Ishtiaq, M., Papaioannou, C., Kim, H., Hwang, K., Lin, Y.-H., Colautti, J., Davison, K., et al. (2022) · CJC Pediatric and Congenital Heart Disease · doi:10.1016/j.cjcpc.2022.11.005 · Cited by 2

Anti-SARS-CoV-2 vaccine-induced myocarditis – real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology

Sousa, J. P., Roque, D., Guerreiro, C., & Teixeira, R. P. (2023) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2023.01.003 · Cited by 2

Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)

Risco-Risco, C., Martínez‐Urbistondo, D., Carrero, R. S. D. V., Ayerbe, L., Pérez-Rubio, A., Barberán-López, J., Andaluz‐Ojeda, D., & Fernández, P. V. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/017.2023 · Cited by 2

COVID-19 infection with complicated fulminant myocarditis: a case report

Miao, K., Lai, J., Wang, F., Wang, L., Zhao, C., & Wang, D. W. (2023) · Cardiology Plus · doi:10.1097/cp9.0000000000000050 · Cited by 2

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data

Dreyfus, J., Munnangi, S., Bengtsson, C., Correia, B., Figueiredo, R. A. D. O., Stark, J. H., Zawora, M., Riddle, M. S., Maguire, J. D., Jiang, Q. L., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.01.037 · Cited by 2

Myocarditis And COVID-19: An Analysis Of All Claims Administrative Data From Before And During The Pandemic

Zadeh, A. V., Wong, A., Collado, E., & Larned, J. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.10.113

Incidence and risk factors of myocarditis in hospitalized patients with COVID‐19

Keller, K., Sagoschen, I., Konstantinides, S., Gori, T., Münzel, T. F., & Hobohm, L. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28646 · Cited by 23

Incidence and risk factors of myocarditis in hospitalized patients with COVID-19 in Germany

Keller, K., Sagoschen, I., Konstantinides, S., Gori, T., Münzel, T. F., & Hobohm, L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad655.1820

Hospitalisations with myocarditis before and during the COVID-19 pandemic – a nationwide cohort study

Héritier, J., Laager, R., Schelldorfer, A., Gregoriano, C., Müeller, B., Schüetz, P., & Kutz, A. (2026) · Swiss Medical Weekly · doi:10.57187/4794

The Impact of COVID‐19 Infection and Vaccination on Myocarditis Incidence: A Comparative Analysis of Pre‐, Peri‐, and Post‐Pandemic Eras

Waksman, O., Abusnina, W. A., Case, B. C., Cellamare, M., Zhang, C., Rappaport, H., Sawant, V., THAKKAR, Y., & Waksman, R. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70659